WARREN F. GORMAN, M.D.; EMANUEL MESSINGER, M.D.; MORRIS HERMAN, M.D.
GORMAN WF, MESSINGER E, HERMAN M. TOXICITY OF THIOCYANATES USED IN TREATMENT OF HYPERTENSION(TOXICITY OF THIOCYANATES USED IN TREATMENT OF HYPERTENSION*). Ann Intern Med. 1949;30:1054-1059. doi: 10.7326/0003-4819-30-5-1054
Download citation file:
Published: Ann Intern Med. 1949;30(5):1054-1059.
The purpose of this article is to describe the toxic effects of thiocyanate as used in the treatment of hypertension, and to report a fatal case of thiocyanate poisoning.
The popularity of thiocyanate (SCN) treatment for hypertension has fluctuated over a period of years. The drug was first studied from a pharmacological standpoint in 1857 by Claude Bernard, but it was not until 1903 that Pauli made use of its hypotensive properties in clinical medicine. In 1925, Westphal commented on its toxic effects. In 1929, the Council on Pharmacy and Chemistry of the American Medical Association
Learn more about subscription options.
Register Now for a free account.
Cardiology, Coronary Risk Factors, Emergency Medicine, Hypertension, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only